Evidence map›Paper›PMID 41861380›Full record

ArticleJMIR AI2026

Artificial Intelligence as a Catalyst for Value-Based Health Insurance in the United States: Narrative Review and Policy Perspective.

Amol Kodan

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Amol KodanDepartment of Public Health, Monroe University, 434 Main St, New Rochelle, NY, 10801, United States, 1 646 393-8479.ORCID http://orcid.org/0009-0005-4823-6594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: The United States health insurance system is at a critical crossroads. Inflating costs, fragmented care, and administrative inefficiencies have revealed the limitations of the Fee-for-Service (FFS) model. This long-standing structure, while once effective in expanding access, now struggles to deliver efficiency and value. Value-based care (VBC) aims to realign incentives toward outcomes, quality, and efficiency. This article explores how artificial intelligence (AI) can serve as the digital backbone to accelerate the transition from FFS to VBC. The article reviews evidence from bundled payment programs and Accountable Care Organizations (ACOs), examines AI-driven frameworks for cost prediction, outcome measurement, and risk adjustment, and discusses associated challenges and future considerations using an illustrative case. Bundled payment models, such as the Comprehensive Care for Joint Replacement program, have shown average savings of approximately $1012 per episode; whereas, the ACO REACH model achieved average savings of roughly $930 per beneficiary, relative to FFS benchmarks. AI applications provide scalable solutions for forecasting costs, optimizing care coordination, and supporting preventive interventions. A case vignette in congestive heart failure illustrates how AI-enabled VBC can reduce episode costs by approximately 20% under favorable implementation conditions. AI has the potential to accelerate the scaling of VBC by enhancing its efficiency, equity, and sustainability. However, realizing this promise requires safeguards for data quality, interoperability, fairness, and transparency. In the AI era, the defining measure of health insurance will shift from the number of claims processed to the number of lives improved.

Indexed as

accountable care organizationsAIartificial intelligencebundled paymentequityFee-For-ServiceFFShealth insurancemachine learningMLtransparencyvalue-based careVBC

Identifiers

PMID41861380
PMCPMC13004588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.